Pharmaceutical companies and the healthcare industry are working to find a vaccine to stem a worsening COVID-19 outbreak. While scientists have made some progress in breaking down the DNA of the virus, the trials for the cure are still a far off. 

Novavax, based in the U.S. state of Maryland, announced that they are advancing their development on an experimental vaccine for COVID-19 and the company's president, Gregory Glenn, MD, explains how the process works.